Dr. Khaled Abdel Ghaffar, Deputy Prime Minister and Minister of Health and Population, met with Dr. Hani Khater, Director of Government Affairs for the Middle East at Abbott Pharmaceuticals, and Dr. Islam Gaber, Regional Director of Abbott for the Middle East and North East Africa, to discuss enhancing cooperation in the healthcare sector. The meeting took place at the Ministry’s headquarters in the New Administrative Capital.
Present at the meeting were Dr. Amr Qandil, Deputy Minister of Health and Population, and Dr. Nancy El-Gendy, Head of the Central Administration for Laboratories.
Dr. Hossam Abdel Ghaffar, the official spokesperson for the Ministry of Health and Population, explained that the Minister began the meeting by welcoming the attendees and expressing appreciation for Abbott’s ongoing collaboration in the health sector. He noted that the meeting aimed to enhance the capabilities of laboratory facilities by providing advanced diagnostic tools for hospitals and clinics, particularly in remote and border areas. Additionally, discussions centered on cooperation in national screening campaigns, expanding the provision of medical devices for diabetes and cardiovascular health, and strengthening the training of healthcare personnel.
Dr. Abdel Ghaffar emphasized that the meeting addressed plans for equipping the Ministry’s Central Laboratories with under the Preventive Medicine Sector. The discussion also included updating laboratory equipment and improving sample transportation systems.
Furthermore, the meeting focused on introducing advanced diagnostic tools for early detection and monitoring of diseases such as diabetes, cardiovascular diseases, and infectious diseases, along with exploring modern technologies for treating cardiovascular conditions. Plans for building capacity through training programs for healthcare providers on the use of Abbott medical devices were also discussed.
The meeting also covered the provision of nutritional programs using Abbott products to combat malnutrition in children and pregnant women, and proposed future collaborative programs to address the growing burden of non-communicable diseases such as diabetes, cardiovascular diseases, and obesity.
